Global Immune Repertoire Sequencing Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 99
Inquire Before Buying

Immune Repertoire is the collection of B and T cells with functional diversity in the body that reflects the immune selectivity. Immune Repertoire Sequencing means to sequence the complimentary determining region of both B-cell receptor and T-cell receptor. Immune receptor repertoire profiling portrays as the antigen-specific information within lymphocytes and has become increasingly significant to understand body's autoimmunity and healthy immunity. This also propose novel ways to tackle cancer and development of personalized medicine by understanding the genetic makeup of a person. Since the last two decades, the technical advancements in the high throughput sequencing techniques along with the development in the bioinformatics and statistical tools have made the immune repertoire sequencing to be analyzed at single sequence level. This technology has potential to explore for the novel infectious agents and also offers new approaches for vaccine or antibody development.

Market Analysis and Insights: Global Immune Repertoire Sequencing Market

The global Immune Repertoire Sequencing market size is projected to reach US$ 128.8 million by 2027, from US$ 103.3 million in 2020, at a CAGR of 3.2% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Immune Repertoire Sequencing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Immune Repertoire Sequencing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Immune Repertoire Sequencing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Immune Repertoire Sequencing market.

Global Immune Repertoire Sequencing Scope and Market Size

Immune Repertoire Sequencing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Immune Repertoire Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Pyro-Sequencing

- Dye-Terminating Sequencing

- Semiconductor Sequencing

- Others

Segment by Application

- Biomarker Discovery

- Infectious Diseases

- Vaccine Development and Efficacy

- Cancer Immunotherapy

- Autoimmune Disease

- Transplant Rejection and Tolerance

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- ArcherDX

- Junom Therapeutics

- Roche Holding

- Illumina

- ThermoFisher Scietific

- Pacific Biosciences

- CD Genomics

- Atreca

- Adaptive Biotechnologies

Global Immune Repertoire Sequencing Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Repertoire Sequencing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pyro-Sequencing
1.2.3 Dye-Terminating Sequencing
1.2.4 Semiconductor Sequencing
1.2.5 Others
1.3 Market by Application
1.3.1 Global Immune Repertoire Sequencing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biomarker Discovery
1.3.3 Infectious Diseases
1.3.4 Vaccine Development and Efficacy
1.3.5 Cancer Immunotherapy
1.3.6 Autoimmune Disease
1.3.7 Transplant Rejection and Tolerance
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immune Repertoire Sequencing Market Perspective (2016-2027)
2.2 Immune Repertoire Sequencing Growth Trends by Regions
2.2.1 Immune Repertoire Sequencing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Immune Repertoire Sequencing Historic Market Share by Regions (2016-2021)
2.2.3 Immune Repertoire Sequencing Forecasted Market Size by Regions (2022-2027)
2.3 Immune Repertoire Sequencing Industry Dynamic
2.3.1 Immune Repertoire Sequencing Market Trends
2.3.2 Immune Repertoire Sequencing Market Drivers
2.3.3 Immune Repertoire Sequencing Market Challenges
2.3.4 Immune Repertoire Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Repertoire Sequencing Players by Revenue
3.1.1 Global Top Immune Repertoire Sequencing Players by Revenue (2016-2021)
3.1.2 Global Immune Repertoire Sequencing Revenue Market Share by Players (2016-2021)
3.2 Global Immune Repertoire Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Immune Repertoire Sequencing Revenue
3.4 Global Immune Repertoire Sequencing Market Concentration Ratio
3.4.1 Global Immune Repertoire Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Repertoire Sequencing Revenue in 2020
3.5 Immune Repertoire Sequencing Key Players Head office and Area Served
3.6 Key Players Immune Repertoire Sequencing Product Solution and Service
3.7 Date of Enter into Immune Repertoire Sequencing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Repertoire Sequencing Breakdown Data by Type
4.1 Global Immune Repertoire Sequencing Historic Market Size by Type (2016-2021)
4.2 Global Immune Repertoire Sequencing Forecasted Market Size by Type (2022-2027)
5 Immune Repertoire Sequencing Breakdown Data by Application
5.1 Global Immune Repertoire Sequencing Historic Market Size by Application (2016-2021)
5.2 Global Immune Repertoire Sequencing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Immune Repertoire Sequencing Market Size (2016-2027)
6.2 North America Immune Repertoire Sequencing Market Size by Type
6.2.1 North America Immune Repertoire Sequencing Market Size by Type (2016-2021)
6.2.2 North America Immune Repertoire Sequencing Market Size by Type (2022-2027)
6.2.3 North America Immune Repertoire Sequencing Market Size by Type (2016-2027)
6.3 North America Immune Repertoire Sequencing Market Size by Application
6.3.1 North America Immune Repertoire Sequencing Market Size by Application (2016-2021)
6.3.2 North America Immune Repertoire Sequencing Market Size by Application (2022-2027)
6.3.3 North America Immune Repertoire Sequencing Market Size by Application (2016-2027)
6.4 North America Immune Repertoire Sequencing Market Size by Country
6.4.1 North America Immune Repertoire Sequencing Market Size by Country (2016-2021)
6.4.2 North America Immune Repertoire Sequencing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Immune Repertoire Sequencing Market Size (2016-2027)
7.2 Europe Immune Repertoire Sequencing Market Size by Type
7.2.1 Europe Immune Repertoire Sequencing Market Size by Type (2016-2021)
7.2.2 Europe Immune Repertoire Sequencing Market Size by Type (2022-2027)
7.2.3 Europe Immune Repertoire Sequencing Market Size by Type (2016-2027)
7.3 Europe Immune Repertoire Sequencing Market Size by Application
7.3.1 Europe Immune Repertoire Sequencing Market Size by Application (2016-2021)
7.3.2 Europe Immune Repertoire Sequencing Market Size by Application (2022-2027)
7.3.3 Europe Immune Repertoire Sequencing Market Size by Application (2016-2027)
7.4 Europe Immune Repertoire Sequencing Market Size by Country
7.4.1 Europe Immune Repertoire Sequencing Market Size by Country (2016-2021)
7.4.2 Europe Immune Repertoire Sequencing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Immune Repertoire Sequencing Market Size (2016-2027)
8.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Type
8.2.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2027)
8.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Application
8.3.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2027)
8.4 Asia-Pacific Immune Repertoire Sequencing Market Size by Region
8.4.1 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immune Repertoire Sequencing Market Size (2016-2027)
9.2 Latin America Immune Repertoire Sequencing Market Size by Type
9.2.1 Latin America Immune Repertoire Sequencing Market Size by Type (2016-2021)
9.2.2 Latin America Immune Repertoire Sequencing Market Size by Type (2022-2027)
9.2.3 Latin America Immune Repertoire Sequencing Market Size by Type (2016-2027)
9.3 Latin America Immune Repertoire Sequencing Market Size by Application
9.3.1 Latin America Immune Repertoire Sequencing Market Size by Application (2016-2021)
9.3.2 Latin America Immune Repertoire Sequencing Market Size by Application (2022-2027)
9.3.3 Latin America Immune Repertoire Sequencing Market Size by Application (2016-2027)
9.4 Latin America Immune Repertoire Sequencing Market Size by Country
9.4.1 Latin America Immune Repertoire Sequencing Market Size by Country (2016-2021)
9.4.2 Latin America Immune Repertoire Sequencing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Repertoire Sequencing Market Size (2016-2027)
10.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Type
10.2.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2027)
10.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Application
10.3.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2027)
10.4 Middle East & Africa Immune Repertoire Sequencing Market Size by Country
10.4.1 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 ArcherDX
11.1.1 ArcherDX Company Details
11.1.2 ArcherDX Business Overview
11.1.3 ArcherDX Immune Repertoire Sequencing Introduction
11.1.4 ArcherDX Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.1.5 ArcherDX Recent Development
11.2 Junom Therapeutics
11.2.1 Junom Therapeutics Company Details
11.2.2 Junom Therapeutics Business Overview
11.2.3 Junom Therapeutics Immune Repertoire Sequencing Introduction
11.2.4 Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.2.5 Junom Therapeutics Recent Development
11.3 Roche Holding
11.3.1 Roche Holding Company Details
11.3.2 Roche Holding Business Overview
11.3.3 Roche Holding Immune Repertoire Sequencing Introduction
11.3.4 Roche Holding Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.3.5 Roche Holding Recent Development
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Immune Repertoire Sequencing Introduction
11.4.4 Illumina Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.4.5 Illumina Recent Development
11.5 ThermoFisher Scietific
11.5.1 ThermoFisher Scietific Company Details
11.5.2 ThermoFisher Scietific Business Overview
11.5.3 ThermoFisher Scietific Immune Repertoire Sequencing Introduction
11.5.4 ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.5.5 ThermoFisher Scietific Recent Development
11.6 Pacific Biosciences
11.6.1 Pacific Biosciences Company Details
11.6.2 Pacific Biosciences Business Overview
11.6.3 Pacific Biosciences Immune Repertoire Sequencing Introduction
11.6.4 Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.6.5 Pacific Biosciences Recent Development
11.7 CD Genomics
11.7.1 CD Genomics Company Details
11.7.2 CD Genomics Business Overview
11.7.3 CD Genomics Immune Repertoire Sequencing Introduction
11.7.4 CD Genomics Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.7.5 CD Genomics Recent Development
11.8 Atreca
11.8.1 Atreca Company Details
11.8.2 Atreca Business Overview
11.8.3 Atreca Immune Repertoire Sequencing Introduction
11.8.4 Atreca Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.8.5 Atreca Recent Development
11.9 Adaptive Biotechnologies
11.9.1 Adaptive Biotechnologies Company Details
11.9.2 Adaptive Biotechnologies Business Overview
11.9.3 Adaptive Biotechnologies Immune Repertoire Sequencing Introduction
11.9.4 Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2016-2021)
11.9.5 Adaptive Biotechnologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Immune Repertoire Sequencing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pyro-Sequencing
Table 3. Key Players of Dye-Terminating Sequencing
Table 4. Key Players of Semiconductor Sequencing
Table 5. Key Players of Others
Table 6. Global Immune Repertoire Sequencing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Immune Repertoire Sequencing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Immune Repertoire Sequencing Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Immune Repertoire Sequencing Market Share by Regions (2016-2021)
Table 10. Global Immune Repertoire Sequencing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Immune Repertoire Sequencing Market Share by Regions (2022-2027)
Table 12. Immune Repertoire Sequencing Market Trends
Table 13. Immune Repertoire Sequencing Market Drivers
Table 14. Immune Repertoire Sequencing Market Challenges
Table 15. Immune Repertoire Sequencing Market Restraints
Table 16. Global Immune Repertoire Sequencing Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Immune Repertoire Sequencing Market Share by Players (2016-2021)
Table 18. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2020)
Table 19. Ranking of Global Top Immune Repertoire Sequencing Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Immune Repertoire Sequencing Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Immune Repertoire Sequencing Product Solution and Service
Table 23. Date of Enter into Immune Repertoire Sequencing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Immune Repertoire Sequencing Revenue Market Share by Type (2016-2021)
Table 27. Global Immune Repertoire Sequencing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Immune Repertoire Sequencing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Immune Repertoire Sequencing Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Immune Repertoire Sequencing Revenue Market Share by Application (2016-2021)
Table 31. Global Immune Repertoire Sequencing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Immune Repertoire Sequencing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Immune Repertoire Sequencing Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Immune Repertoire Sequencing Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Immune Repertoire Sequencing Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Immune Repertoire Sequencing Market Size by Country (2022-2027) & (US$ Million)
Table 63. ArcherDX Company Details
Table 64. ArcherDX Business Overview
Table 65. ArcherDX Immune Repertoire Sequencing Product
Table 66. ArcherDX Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 67. ArcherDX Recent Development
Table 68. Junom Therapeutics Company Details
Table 69. Junom Therapeutics Business Overview
Table 70. Junom Therapeutics Immune Repertoire Sequencing Product
Table 71. Junom Therapeutics Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 72. Junom Therapeutics Recent Development
Table 73. Roche Holding Company Details
Table 74. Roche Holding Business Overview
Table 75. Roche Holding Immune Repertoire Sequencing Product
Table 76. Roche Holding Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 77. Roche Holding Recent Development
Table 78. Illumina Company Details
Table 79. Illumina Business Overview
Table 80. Illumina Immune Repertoire Sequencing Product
Table 81. Illumina Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 82. Illumina Recent Development
Table 83. ThermoFisher Scietific Company Details
Table 84. ThermoFisher Scietific Business Overview
Table 85. ThermoFisher Scietific Immune Repertoire Sequencing Product
Table 86. ThermoFisher Scietific Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 87. ThermoFisher Scietific Recent Development
Table 88. Pacific Biosciences Company Details
Table 89. Pacific Biosciences Business Overview
Table 90. Pacific Biosciences Immune Repertoire Sequencing Product
Table 91. Pacific Biosciences Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 92. Pacific Biosciences Recent Development
Table 93. CD Genomics Company Details
Table 94. CD Genomics Business Overview
Table 95. CD Genomics Immune Repertoire Sequencing Product
Table 96. CD Genomics Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 97. CD Genomics Recent Development
Table 98. Atreca Company Details
Table 99. Atreca Business Overview
Table 100. Atreca Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 101. Atreca Recent Development
Table 102. Adaptive Biotechnologies Company Details
Table 103. Adaptive Biotechnologies Business Overview
Table 104. Adaptive Biotechnologies Immune Repertoire Sequencing Product
Table 105. Adaptive Biotechnologies Revenue in Immune Repertoire Sequencing Business (2016-2021) & (US$ Million)
Table 106. Adaptive Biotechnologies Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Repertoire Sequencing Market Share by Type: 2020 VS 2027
Figure 2. Pyro-Sequencing Features
Figure 3. Dye-Terminating Sequencing Features
Figure 4. Semiconductor Sequencing Features
Figure 5. Others Features
Figure 6. Global Immune Repertoire Sequencing Market Share by Application: 2020 VS 2027
Figure 7. Biomarker Discovery Case Studies
Figure 8. Infectious Diseases Case Studies
Figure 9. Vaccine Development and Efficacy Case Studies
Figure 10. Cancer Immunotherapy Case Studies
Figure 11. Autoimmune Disease Case Studies
Figure 12. Transplant Rejection and Tolerance Case Studies
Figure 13. Others Case Studies
Figure 14. Immune Repertoire Sequencing Report Years Considered
Figure 15. Global Immune Repertoire Sequencing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 16. Global Immune Repertoire Sequencing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 17. Global Immune Repertoire Sequencing Market Share by Regions: 2020 VS 2027
Figure 18. Global Immune Repertoire Sequencing Market Share by Regions (2022-2027)
Figure 19. Global Immune Repertoire Sequencing Market Share by Players in 2020
Figure 20. Global Top Immune Repertoire Sequencing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Repertoire Sequencing as of 2020
Figure 21. The Top 10 and 5 Players Market Share by Immune Repertoire Sequencing Revenue in 2020
Figure 22. Global Immune Repertoire Sequencing Revenue Market Share by Type (2016-2021)
Figure 23. Global Immune Repertoire Sequencing Revenue Market Share by Type (2022-2027)
Figure 24. North America Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. North America Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 26. North America Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 27. North America Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 28. United States Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Canada Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 32. Europe Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 33. Europe Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 34. Germany Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. France Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. U.K. Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Italy Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Russia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Nordic Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 42. Asia-Pacific Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 43. Asia-Pacific Immune Repertoire Sequencing Market Share by Region (2016-2027)
Figure 44. China Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Japan Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. South Korea Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Southeast Asia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. India Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Australia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 52. Latin America Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 53. Latin America Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 54. Mexico Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Brazil Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Immune Repertoire Sequencing Market Share by Type (2016-2027)
Figure 58. Middle East & Africa Immune Repertoire Sequencing Market Share by Application (2016-2027)
Figure 59. Middle East & Africa Immune Repertoire Sequencing Market Share by Country (2016-2027)
Figure 60. Turkey Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Saudi Arabia Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. UAE Immune Repertoire Sequencing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. ArcherDX Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 64. Junom Therapeutics Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 65. Roche Holding Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 66. Illumina Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 67. ThermoFisher Scietific Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 68. Pacific Biosciences Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 69. CD Genomics Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 70. Atreca Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 71. Adaptive Biotechnologies Revenue Growth Rate in Immune Repertoire Sequencing Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
  • Global Digital PCR (DPCR) and QPCR Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 27-Jul-2021        Price: US 5900 Onwards        Pages: 123
    Real-time PCR or quantitative PCR is a well-established technology that has become the tool of choice for the rapid, sensitive quantification of nucleic acid in various biological samples. qPCR measures the accumulation of DNA during a PCR reaction. The increase in quantity of DNA at each cycle is measured by the change in intensity of a fluorescent signal. Comparison to a reference sample determines the number of original copies of template DNA in the reaction.Digital PCR is a highly precise ap......
  • Nucleic Acid Labeling Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 25-Jul-2021        Price: US 3200 Onwards        Pages: 115
    This report describes the global market size of Nucleic Acid Labeling from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also in......
  • Expression Vectors Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 25-Jul-2021        Price: US 3200 Onwards        Pages: 109
    This report describes the global market size of Expression Vectors from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also inclu......
  • Competent Cells Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application
    Published: 25-Jul-2021        Price: US 3200 Onwards        Pages: 101
    This report describes the global market size of Competent Cells from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also included......
  • Single-Cell Analysis Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type
    Published: 25-Jul-2021        Price: US 3200 Onwards        Pages: 120
    This report describes the global market size of Single-Cell Analysis from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026. For geography segment, regional supply, demand, major players, price is presented from 2016 to 2026. This report cover following regions: North America South America Asia & Pacific Europe MEA The key countries for each regions are also inc......
  • Global Somatostatin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 23-Jul-2021        Price: US 5900 Onwards        Pages: 133
    Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin. Global Somatostatin key players include Merck (Schweiz) AG, SANOFI-AVENTIS FRANCE, Lyomark Pharma GmbH, ALFA WASSERMANN S.p.A., HYBIO, etc. Global top five manufacturers hold a share ov......
  • Global Cytokines Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 22-Jul-2021        Price: US 5900 Onwards        Pages: 126
    Cytokines are a large group of small signaling molecules that function extensively in cellular communication. Cytokines are most often associated with various immune modulating molecules that include interleukins, chemokines, and interferons, but can also include other molecules as well. Their use in disease diagnosis and treatment has proven very beneficial over the past number of years as their use as biomarkers has been adopted as a means to understanding disease and therapies. They have expa......
  • Global Western Blot Imagers Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 22-Jul-2021        Price: US 5900 Onwards        Pages: 111
    Western blotting technique or protein immunoblot is used for detection and quantification of specific protein molecules in the given complex protein sample. Western Blot Imager is an important instrument devices use to study and diagnosis of health conditions and diseases, including HIV. Global Western Blot Imagers key players include Bio-Rad, Bio-Techne(ProteinSimple), GE Healthcare Life Sciences, Thermo Fisher Scientific, Syngene, etc. Global top five manufacturers hold a share o......
  • Global Epidermal Growth Factor (EGF) (CAS 62253-63-8) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027
    Published: 21-Jul-2021        Price: US 5900 Onwards        Pages: 117
    Epidermal growth factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival. EGF considerably increases skin cell regeneration. More precisely, they can directly communicate to the skin cells to produce more collagen and elastin, that's why most sk......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs